|
Fecal bile acids and neutral sterols in hamsters treated with G. lucidum and lovastatin (nmol/g dry feces/d) |
|||||||||||
| Bile acids |
Neutral Sterols |
||||||||||
|
|
|||||||||||
| Group |
C |
LC |
DC |
CDC |
UDC |
Total BA |
COP-ol |
COP-3-one |
CHOL erol |
CHOL anol |
Total NS |
|
|
|||||||||||
| Control |
15.0 |
14.3 |
10.7 |
5.1 |
1.7 |
46.7 |
11.5 |
ND |
7.2 |
18.4 |
37.1 |
| Lovastatin |
15.0 |
12.8 |
11.6 |
6.2 |
1.6 |
47.1 |
12.0 |
ND |
6.7 |
18.9 |
37.6 |
| Gl (2.5%) |
16.9 |
16.2 |
14.3 |
8.5a |
1.9 |
57.8a |
11.7 |
4.2a |
7.7 |
16.9 |
40.6 |
| Gl (5%) |
12.2 |
13.9 |
12.0 |
6.4 |
1.4 |
45.8 |
12.0 |
7.8a |
7.0 |
14.1a |
41.0 |
|
Feces were collected quantitatively at the conclusion of the experiment (D18). C, cholate; LC, lithocholate; DC, deoxycholate; CDC, chenodeoxycholate, UDC, Ursodeoxycholate; COP, coprostan; CHOL, cholest; BA, bile acids; NS, neutral sterols. ND, not detected. Values represent mean of 6 determinations. aSignificantly different from the control (P < 0.05), students unpaired, 2-tailed t-test, equal variances. No statistical trends (P < 0.10) existed in the data set. | |||||||||||
Berger et al. Lipids in Health and Disease 2004 3:2 doi:10.1186/1476-511X-3-2 |
|||||||||||